
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
DIO1 CRISPR/Cas9 KO Plasmid (m) | sc-420002 | 20 µg | $397.00 |
Mouse Dio1 encodes iodothyronine deiodinase 1 (DIO1), a selenoenzyme that catalyzes outer- and inner-ring deiodination of thyroid hormones, contributing to peripheral conversion of thyroxine (T4) to bioactive triiodothyronine (T3) and to hormone clearance. DIO1 activity supports endocrine and metabolic homeostasis by shaping intracellular and circulating thyroid hormone availability, thereby influencing transcriptional programs controlled by thyroid hormone receptors. Dio1 is prominently studied in the context of hepatic and renal thyroid hormone metabolism, selenium biology, and redox-dependent enzyme function. Altered deiodinase expression or activity has been associated with dysregulated thyroid hormone signaling in metabolic and inflammatory states, motivating mechanistic studies of Dio1-dependent pathways in mouse models.
DIO1 CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Dio1 gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Dio1 together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Dio1 open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish DIO1 protein expression.
This CRISPR knockout system enables efficient generation of Dio1-deficient cell models for investigation of DIO1 signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.